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Abstract
We have previously identified an Alu-derived Intronic Splicing enhancer (ISE) in the Ataxia Teleangectasia Mutated gene
(ATM) that facilitates intron pre-mRNA processing and leads to the inclusion of a cryptic exon in the final mRNA transcript.
By using an RNA pull-down assay, we show here that hnRNPA1/A2, HuR and DAZAP1 splicing factors and DHX36 RNA
helicase bind to the ISE. By functional studies (overexpression and siRNA experiments), we demonstrate that hnRNPA1 and
DAZAP1 are indeed involved in ISE-dependent ATM cryptic exon activation, with hnRNPA1 acting negatively and DAZAP1
positively on splicing selection. On the contrary, HuR and DHX36 have no effect on ATM splicing pattern. These data
suggest that splicing factors with both negative and positive effect can assemble on the intronic Alu repeats and regulate
pre-mRNA splicing.
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Introduction
Accurate intron excision and exon joining during the process of
pre-mRNA splicing, enable generation of mature mRNAs that
contain continuous coding sequence for protein synthesis. Precise
pre-mRNA splicing depends on the presence of splicing consensus
sequences at 59 and 39 exon splice sites and additional intronic and
exonic regulatory elements [1]. These elements are defined as
Splicing Enhancer or Silencers according to their effect on splice
site selection and are involved in normal and aberrant splicing
regulation [2]. Differently from classical splice sites, enhancers and
silencers are highly degenerated sequences that affect splicing
through their interaction with regulatory splicing factors and/or
RNA secondary structure [1]. RNA-binding factors are key
splicing regulators as their interaction with intronic and/or exonic
sequences contributes to the splicing outcome. In general, each
splicing factor has a positive or a negative effect on splicing, for
example SR proteins are considered enhancers whereas
hnRNPA1/A2 are silencers, but frequently the final effect on
splicing is based on their binding position [3], which reflects
specific interactions with multiple spliceosomal components on the
nascent transcripts.
Genomic variants located in ‘‘deep’’ intronic regions, far away
from exon/intron junctions, may alter the pattern of splicing
leading to generation of aberrantly spliced products. In the majority
of cases, these mutations affect the classical cis-acting elements
required for exon definition like the splice sites sequences [4].
However, in some cases, mutations may affect different splicing
regulatory elements that are important for intron processing. We
previously reported a particular four nucleotides-long GTAA
deletion in the ATM intron 20, which affects normal intron
processing: it activates a cryptic exon inclusion in the final mRNA
transcript and cause ataxia telangiectasia in affected patients [5].
Activation of the cryptic exon is a result of a complex mechanism
that includes several cis-acting elements, which are involved in
aberrant processing of the intron. In fact, this mutation occurs
12 bp downstream and 53 bp upstream of the cryptic exon splice
sites, respectively, and activates a weak cryptic GC 59 splice site.
Moreover, this mutation leads to the disruption of an Intronic
Splicing Processing Element (ISPE) that is located between these
two cryptic sites: the GTAA deletion actually abolishes the non-
canonical interaction of U1 snRNP with the ISPE [5]. This further
leads to a stringent 59-39 order of intron removal around the ATM
crypticexon bypromoting the splicingoftheupstream introndueto
the removal of the steric hindrance from the adjacent upstream
cryptic 39 splice site [6,7]. This eventually results in generation of
the 59 splicing intermediate that contains the downstream portion of
the ATM intron 20. Interestingly, the splicing defect is modulated
by an Alu-derived Intronic Splicing Enhancer (ISE), that is
indispensable for the inclusion of the cryptic exon in the final
mRNAtranscript [8]. This40-nt longISEelement resides withinan
inverted Alu repeat situated downstream of the cryptic exon thus
suggesting an interesting impact of this primate-specific mobile
element in modulation of ATM cryptic exon activation. Actually,
the effect of Alu repeats on the pre-mRNA splicing is relevant for
human pathology and primate-specific evolution as their intronic
insertion has already been associated with pathological skipping of
adjacent exons in several human diseases [9,10]. Furthermore,
genome-wide analyses showed that many Alu repeats preferentially
flank alternatively spliced exons rather than constitutively spliced
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of the flanking exons and affect the splicing outcome [11]. The ISE
in the ATM intron 20 acts in a peculiar manner facilitating intron
pre-mRNA processing of the aberrant transcript. In fact, whereas
the excision of the upstream portion of ATM intron 20 and
generation of the 59 splicing intermediate occur regardless of the
presence of the ISE, further processing of the precursor is ISE-
dependent [8]. Intermediates that lack this regulatory element do
not give rise to the mature mRNA that contains the cryptic exon.
The ISE-mediated processing of the 59 splicing intermediate is also
relatedtotheinefficientrecognition oftheweak cryptic GC 59 splice
site by U1 snRNP [8].
To better understand the function of the Alu-derived ISE in
intron processing, we explored its binding properties towards trans-
acting factors. We found that several splicing factors specifically
bind to the ISE. Functional analysis with over-expression and
siRNA experiments showed that the ISE-mediated cryptic exon
activation involves hnRNPA1 and DAZAP1 trans-acting factors
whose interaction with this regulatory element modulates ATM
splicing outcome. As the human genome harbors a large amount
of similar Alu-derived regulatory elements, it suggests that their
potential interaction with these trans-acting factors may represent a
widespread phenomenon with effect on pre-mRNA processing
and alternative splicing regulation.
Results
Identification of nuclear proteins that differentially bind
to the ISE wt and ISE mutated sequences
The basic pATMD hybrid minigene construct comprised the
entire sequence of ATM intron 20 flanked by ATM exons 20 and
21 and embedded in the a-globin context (Fig. 1A). As previously
reported, pATMD construct, which contains the four bp deletion
found in patient, generates an aberrantly spliced product with
,83% of cryptic exon inclusion whereas removal of the
downstream ISE restores normal pattern of splicing (Fig. 1B,
pDSH5). Similarly, the introduction of eight nucleotide changes
across the ISE also leads to the complete exclusion of the cryptic
exon from the mature mRNA transcript (Fig. 1B, pDmut).
To identify specific trans-acting factors whose differential
binding to the wild type and mutated regulatory element could
provide the explanation for observed changes in the splicing
pattern, we carried out a pull down assay using the ISE wt and ISE
mutated element. The pull down experiment revealed several
protein bands exclusively enriched in ISE wt and not in the ISE
mut oligonucleotide fraction. These protein bands were excised
from gel, sequenced performing electrospray mass spectrometry
analysis and eventually identified as ATP-dependent RNA helicase
DHX36 (Uniprot accession number Q9H2U1), DAZAP1 (Deleted
in AZoospermia-Associated Protein 1, Uniprot accession number
Q96EP5) and HuR (Hu-antigene R, Uniprot accession number
Q15717) proteins, respectively. To confirm the differential binding
capacity, immunoblot experiment was performed including in the
analysis some proteins whose role in splicing regulation is well
described in the literature: hnRNPA1 and PTB proteins as well as
SF2/ASF protein. The immunoblot analysis confirmed the
presence of RNA helicase DHX36, DAZAP1 and HuR proteins
only in the ISE wt fraction and revealed that also hnRNPA1
protein was enriched in ISE wt fraction (Fig. 1C). PTB protein was
present in equal amounts in both ISE wt and ISE mut samples
while SF2/ASF protein had no binding affinity towards either of
the two sequences. Altogether these results indicate that RNA
helicase DHX36, DAZAP1, HuR and hnRNPA1 proteins
specifically interact in vitro with the ISE.
Figure 1. Analysis of the ISE binding capacity. A) Schematic
representation of the pATM minigene. a-globin and ATM exons are
white and grey boxes, respectively, and introns are lines. The cryptic
65 bp ATM exon activated by the GTAA deletion (D) is indicated and
the oval show the position of the ISE. Splicing pattern is represented
with diagonal dashed lines and the arrows indicate location of the
primers used in RT-PCR analysis. The nucleotide sequence of normal
and mutant ISE is shown. B) Splicing assay. The pD minigenes were
transfected in HeLa cells and the pattern of splicing analyzed with E16
and 2550 primers. In pDSH5 the ISE has been deleted. RT-PCR
fragments were resolved on 2% agarose gel. M is the molecular weight
marker. The cryptic exon inclusion and exclusion are indicated. The
asterisk corresponds to a minor spliced product without the hybrid
exon made of globin exon 3 and ATM exon 20. The % of cryptic exon
inclusion is indicated and is the mean of three independent
experiments. C) Western blot analysis of pull down assay performed
on ISE wt and ISE mut sequences. The binding analysis of RNA helicase
DHX36, DAZAP1, HuR, hnRNPA1, PTB and SF2/ASF protein. Upon in vitro
transcription, RNAs were covalently bound to the agarose beads and
incubated with HeLa nuclear extract. After washing steps, the pulled
down proteins were loaded on SDS-PAGE gel and analyzed by western
blotting using antibodies against RNA helicase DHX36, DAZAP1, HuR,
hnRNPA1, PTB and SF2/ASF proteins. The nuclear extract (NE)
corresponds to the 1/20 of the amount used in pull down assay. ISE
wt sequence pulled down RNA helicase DHX36, DAZAP1, HuR, hnRNPA
and PTB whereas the ISE mut fraction was enriched only in PTB. SF2/ASF
was not detected in either of fractions.
doi:10.1371/journal.pone.0023349.g001
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hnRNPA1 overexpression on ATM cryptic exon activation
To address the functional role of these trans-acting factors in ATM
cryptic exon activation, we performed cotransfecton experiments
using minigene constructs with and without the ISE (pATMD and
pDSH5, respectively). These constructs were transfected into HeLa
cells alone or along with expression vectors for DHX36, DAZAP1,
HuR and hnRNPA1 proteins whose effect on the minigene splicing
pattern was evaluated by RT-PCR. Expression of all four
recombinant proteins was confirmed by conducting the western
blot analyses using anti-flag antibody (Fig. S1).
The splicing of the ISE-containing pre-mRNA construct
(pATMD) was affected only by the overexpression of hnRNPA1
protein whereas the overexpression of other candidate proteins had
no effect on the pattern of splicing (Fig. 2). In particular, hnRNPA1
overexpression led to a decrease of cryptic exon inclusion from 80%
to 10% in pATMD (Fig. 2, lane3). On the other hand, pDSH5
construct that lacks the ISE element did not respond to the
increased amount of any of proteins tested (Fig. 3, lanes 7–12). In
order to see whether RNA helicase DHX36, DAZAP1 and HuR
protein caninducesome effectonATMcrypticexon inclusionupon
co-expression, we performed the experiment in which overexpres-
sion of these three proteins was combined in different manners.
Neither overexpression of two different proteins in all three
combinations nor simultaneous overexpression of HuR, DAZAP1
and DHX36 showed any effect on tested minigene constructs
(Fig. 3). In addition, the decrease of cryptic exon inclusion induced
by hnRNPAI in pATMD was not affected by the simultaneous
coexpression of the other splicing factors (data not shown).
Effect of siRNA against RNA helicase DHX36, DAZAP1,
HuR and hnRNPA1 on ATM cryptic exon activation
In order to evaluate the functional role of RNA helicase
DHX36, DAZAP1, HuR and hnRNPA1/A2 on ATM cryptic
exon activation, we depleted these proteins from cells by
performing siRNA treatment.
In vivo depletion of DHX36, DAZAP1, HuR and hnRNPA1/A2
proteins was achieved by transient transfection of siRNA
oligonucleotides directed toward corresponding proteins. All
siRNA treatments induced significant reduction of the target
protein level (Fig. 4A). Silencing of DHX36, HuR and DAZAP1
was complete while siRNA against hnRNPA1/A2 led to 90% of
protein reduction. The cells treated with different siRNAs were
transfected with pATMD and pDSH5 minigene constructs. The
siRNA treatment against hnRNPA1 led to an increase in the ATM
cryptic exon inclusion up to 95% in pATMD context (Fig. 4B, lane
3) but had no effect on pDSH5 constructs (Fig. 4B, lane 9).
Depletion of DAZAP1 induced a mild ATM cryptic exon
exclusion in pATMD-deriving mature mRNA transcripts
(Fig. 4B, lane 4) and had no effect on transcripts that lack the
ISE (Fig. 4B, lane10). The siRNA treatments against RNA
helicase DHX36 and HuR had no effect on either of tested pATM
minigenes regardless of the presence of the ISE (Fig. 4B).
Altogether these data demonstrate a functional role for
hnRNPA1/A2 and DAZAP1 protein in ATM cryptic exon
activation and show that these trans-acting factors have an opposite
effect on ISE-mediated cryptic exon inclusion, with hnRNPA1/A2
promoting the cryptic exon exclusion and DAZAP1 facilitating
cryptic exon inclusion in the final mRNA.
Figure 2. Effect of RNA helicase DHX36, DAZAP1, HuR and hnRNPA1 overexpression on ATM cryptic exon activation of pATMD and
pDSH5 minigenes. (A) HeLa cells were transfected with pATMD and pDSH5 minigenes in presence of empty expression vector (lanes 2 and 8,
respectively) or vectors expressing the protein of interest (lanes 3-6 and 9-12, respectively). The splicing pattern was analyzed with the E16 and 2550
primers. RT-PCR fragments were resolved on 2% agarose gel. M is the molecular weight marker. On the right is indicated the splicing product with (+)
or without (-) cryptic exon inclusion. The asterisk corresponds to a minor spliced product without the hybrid exon made of globin exon 3 and ATM
exon 20. (B) The graph is the quantification of three independent experiments expressed as means 6SD.
doi:10.1371/journal.pone.0023349.g002
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Genomic variants that affect splicing regulatory elements can
alter the normal pattern of splicing and consequently cause or
modify the severity of human diseases. Their effect depends on the
complex interplay between cis-acting elements, which reside both
in exonic and intronic regions, and trans-acting factors that they
interact with. However, the function of intronic sequences in
modulation of pre-mRNA splicing is poorly understood so the
analyses of intronic mutations can help in elucidating the intronic
determinants of the splicing code. The deletion of 4 bp (GTAA)
within the ATM intron 20 has previously been reported to affect
the process of splicing, leading to the ATM cryptic exon activation
and eventually generating an aberrantly spliced mature mRNA.
This deep intronic GTAA deletion in the ATM gene differs from
the majority of described intronic variants as it is not directly
related to the changes at splice sites but instead affects an Intronic
Splicing Processing Element (ISPE) whose disruption then
abolishes a non-canonical interaction with U1 snRNP and
consequently leads to the activation of two nearby cryptic splice
sites [5]. However, this mutation per se does not give rise to the
aberrant mature RNA transcript as its production depends on the
downstream Alu-derived ISE. To test the hypothesis that ISE-
dependent cryptic exon activation requires interaction of the ISE
with trans-acting factors, the binding capacity of the ISE sequence
was evaluated and four proteins with binding affinity towards ISE
element were detected: RNA helicase DHX36, DAZAP1,
hnRNPA1 and HuR (Fig. 4). HuR is an RNA-binding protein
that shuttles between the cytoplasm and the nucleus and binds
with high affinity to AU-rich elements (AREs) [12]. HuR was
originally reported to be implicated in stabilization of ARE-
containing mRNAs but it has been recently shown that is also
involved in splicing regulation where it promotes Fas exon 6
skipping by binding to an exonic splicing silencer [13]. Recent
work also reports an extensive association of HuR with hnRNP
proteins within the mRNP complex in the nucleus and cytoplasm
suggesting a very important role of HuR in mRNA processing
[14]. A few data are available for RNA helicase DHX36 that has
been found to be involved in degradation and deadenylation of
mRNAs containing ARE sequence element in their 39-UTR [15].
This substrate ‘‘specificity’’ is mediated indirectly by its RNA-
dependent interaction with the ARE-binding proteins HuR and
NFAR1 and it is believed that RNA helicase DHX36 might
actually serve as a ‘‘molecular motor’’ to drive the mechanics of
complex RNA remodeling/decay reactions through interactions
with HuR and NFAR proteins [15]. Interestingly, there exist two
different isoforms of RNA helicase DHX36, which are generated
through alternative splicing and that differ in an 8-amino acids
long sequence that encodes for a nuclear localization signal (NLS).
The RNA helicase DHX36 isoform that we detected in pull down
Figure 3. Effect of RNA helicase DHX36, DAZAP1 and HuR co-expression on ATM cryptic exon activation of pATMD and pDSH5
minigenes. (A) HeLa cells were transfected with pATMD minigene in presence of empty expression vector (lanes 2) or different combinations of
vectors expressing the RNA helicase DHX36, DAZAP1 and HuR protein of interest (lanes 3-6). The splicing pattern was analyzed with the E16 and 2550
primers. RT-PCR fragments were resolved on 2% agarose gel. M is the molecular weight marker. On the right is indicated a splicing product with (+)o r
without (-) cryptic exon inclusion. The asterisk corresponds to a minor spliced product without the hybrid exon made of globin exon 3 and ATM exon
20. The % of cryptic exon inclusion is indicated and is the mean of two independent experiments. (B) HeLa cells were transfected with pDSH5
minigene in presence of empty expression vector (lane 2) or different combinations of expression vectors for RNA helicase DHX36, DAZAP1 and HuR
protein (lanes 3-6). The splicing pattern was analyzed with E16 and 2550 primers. RT-PCR fragments were resolved on 2% agarose gel. M is the
molecular weight marker. On the right is indicated a splicing product with (+) or without (-) cryptic exon inclusion.
doi:10.1371/journal.pone.0023349.g003
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protein in nuclear mRNA processing. DAZAP1 is involved in
mRNA transport, stability and translational regulation [16]. This
protein was shown to interact with many members of hnRNP
family of proteins including the hnRNPA1 protein [17].
Considering that these two proteins are shuttling proteins, their
interaction is considered to be important not only for mRNA
export but also for splicing. In fact, DAZAP1 together with
hnRNPA1/A2 binds to an exonic splicing silencer and promotes
skipping of BRCA1 exon 18 thus revealing the role of DAZAP1 in
pre-mRNA splicing regulation [18]. hnRNPA1 is a well-
characterized splicing factor that exhibits an inhibitory role on
Figure 4. Depletion of hnRNPA1 and DAZAP1 affects splicing of ISE-containing pATMD construct. A) Western blot analysis of HeLa cells
treated with siRNA oligonucleotides against RNA helicase DHX36, DAZAP1, HuR and hnRNPA1 protein. siRNA against luciferase was used as a control.
The western blot was carried out using antibodies that were specific for each target protein. Tubulin was used as a control of the amount of protein
loaded on gel. NE stands for nuclear extract. The siRNA experiment is representative of two independently performed experiments. Protein depletion
observed was almost complete. B) siRNA-treated and untreated HeLa cells were transfected with pATMD and pDSH5 minigene constructs and the
splicing pattern was analyzed by RT-PCR. RT-PCR fragments were resolved on 2% agarose gel. M is the molecular weight marker. The resulting
splicing products with cryptic exon inclusion (+) or exclusion (-) are indicated. The identity of siRNAs that were used to knock-down corresponding
proteins is indicated. C) The graph is the quantification of three independent experiments expressed as means 6SD.
doi:10.1371/journal.pone.0023349.g004
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hnRNPA1 interaction with the other two shuttling proteins and
splicing factors, HuR and DAZAP1, has been demonstrated to
occur extensively both in the cytoplasm and the nucleus thus
indicating their functional link in mRNA metabolism.
To address the functional role of these four proteins in ATM
cryptic exon activation, we performed overexpression experiments
and siRNA treatments on ISE-containing construct (pATMD) and
constructs without the ISE (pDSH5). While the overexpression of
hnRNPA1 led to a diminished level of cryptic exon inclusion in
ISE-containing constructs (Fig. 2), no effect was observed on either
of tested constructs upon overexpression of RNA helicase DXH36,
DAZAP1 and HuR (Fig. 2). Additionally, no changes in splicing
pattern of tested minigenes were detected upon coexpression of
RNA helicase DXH36, DAZAP1 and HuR (Fig. 3). On the other
hand, depletion of candidate proteins revealed that hnRNPA1 and
DAZAP1 induced changes in ATM cryptic exon inclusion on ISE-
containing constructs (Fig. 4) whereas RNA helicase DHX36 and
HuR depletion did not affect the cryptic exon inclusion in neither
of tested constructs. In fact, the siRNA treatment against
hnRNPA1/A2 and DAZAP1 had an opposite effect on cryptic
exon activation as depletion of hnRNPA1 led to an increase in
cryptic exon inclusion while DAZAP1 knock down induced a
modest increase in cryptic exon exclusion suggesting that
hnRNPA1/A2 and DAZAP1 proteins regulate ATM cryptic exon
inclusion probably in an ISE-dependent manner.
The observation that hnRNPA1/A2 proteins acts to inhibit
ATM cryptic exon inclusion is consistent with its negative role in
pre-mRNA processing, while the DAZAP1 enhancing effect on
ATM cryptic exon inclusion represents a new finding as this
protein was previously described to perform exclusively as a
splicing inhibitor [18,20]. The antagonistic effect of hnRNPA1/
A2 and DAZAP1 splicing factors points out a complex interplay
between positive and negative factors in ATM cryptic exon
inclusion. Although a direct proof of competitive interaction of
these proteins with the ISE is missing, it is possible that
hnRNPA1/A2 and DAZAP1 proteins compete for the same
target sequence. However, an alternative explanation for the ISE-
mediated antagonistic effect of hnRNPA1/A2 and DAZAP1 on
cryptic exon activation could be that the ISE represents a more
complex regulatory element that contains both enhancing and
silencing sequences, whose function can be modulated by ISE-
flanking sequences or affected by ISE-secondary structure
determinants. Nevertheless, considering that hnRNPA1/A2 and
DAZAP1 are abundant cellular proteins, that ISPE deletion in ISE
context leads to 85% of cryptic exon inclusion and that depletion
of DAZAP1 has only a modest effect on cryptic exon exclusion, it
is more likely that other still unknown trans-acting factors are
implicated in ISE-dependent enhancement of ATM cryptic exon
inclusion in the mature mRNA. The apparent discrepancy
between the overexpression and the knockdown experiments of
DAZAP1 may be simply due to the fact that this splicing factor is
an abundant cellular protein present at saturating concentration in
vivo. Thus, a further increase in DAZAP1 level will not affect
splicing. We observed previously a similar case where the splicing
pattern was largely unresponsive to overexpression of a splicing
factor but very sensitive to its depletion [21]. However, since
recent reports demonstrate that some short non-coding nuclear
RNAs can be implicated in modulation of the pattern of splicing
through interaction with their target sequences within the pre-
mRNAs [22], we cannot exclude the possibility that these small
regulatory non-coding RNA transcripts can also interact with the
Alu-deriving ISE element and contribute to the ATM cryptic exon
activation. Despite the fact that functional assays did not show any
effect of RNA helicase DHX36 and HuR on cryptic exon
inclusion, involvement of these proteins in regulation of cryptic
exon activation cannot be completely ruled out as it might be that
their effect on processing of ATM intron 20 and aberrant cryptic
exon activation is compensated by other proteins that are yet to be
identified.
In conclusion, we have identified two splicing factors,
hnRNPA1/A2 and DAZAP1, that regulate ATM cryptic exon
inclusion in an ISE-dependent manner. These splicing factors
might be part of a large proteins complex that is assembled on
intronic Alu-derived splicing regulatory elements to regulate pre-
mRNA processing.
Materials and Methods
Analysis of the hybrid minigene expression
pATMD,p DSH5 and pATMDmut minigene constructs have
been previously described [6,8]. HeLa cells (2610
6) (ATCC, Cat.
No. CCL-2) were grown in standard conditions and transfected
with 500 ng of each minigene plasmid using Effectene reagent
[18]. RNA extraction and RT-PCR of amplified products were
done as previously described [23]. Quantification of the
percentage of exon inclusion was performed on Et-Br agarose
gels images using ImageJ 1.38 software (http://rsb.info.nih.gov/
ij/) [23]. For the analysis of spliced forms pATM minigenes were
amplified with E16 dir and ATM 2550 rev [8]. For cotransfection
experiments HeLa cells were transfected with 500 ng of the
minigene construct together with 500 ng of empty pCMVFlag
expression vector or pCMV vector expressing the Flag-tagged
proteins (HuR, DAZAP1, hnRNPA1 and DHX36 helicase). The
expression of all four recombinant proteins was confirmed by
western blot analysis using anti-flag antibody.
Affinity purification of RNA-binding proteins (pull-down
analysis) and mass spectrometry
The synthetic oligonucleotides were purchased from Sigma,
annealed and cloned in pBluescript KS vector under the T7 RNA
promoter. The sequences of oligos are listed in the Table S1. In
vitro transcription was carried out with T7 RNA Polymerase
(Promega) according to standard procedure. Approximately 10 mg
of in vitro transcribed and purified RNA was placed in 400 mlo f
reaction mixture (100 mM NaOAc pH 5.0 and 5 mM sodium m-
periodate), incubated in the dark at room temperature for 1 hour,
precipitated with ethanol and finally resuspended in 100 mlo f
100 mM NaOAc pH 5.0. In the meantime, 400 ml of adipic acid
dehydrazide agarose beads 50% slurry were equilibrated with
100 mM NaOAc (pH 5.2), The beads were then added to each
periodate-treated RNA and the mixture was incubated on a
rotator at 4uC for 12 hours. The complex RNA-beads was then
washed three times with 1 ml of 2 M NaCl, equilibrated in 1x
Solution D (20 mM HEPES pH 7.5, 100 mM KCl, 0.2 mM
EDTA, 0.5 mM DTT and 6% glycerol) and incubated, in the final
volume of 500 ml, with 0.5 mg of HeLa cell nuclear extract (C4,
Biotech), 10x solution D without KCl (200 mM HEPES pH 7.5,
2 mM EDTA, 5 mM DTT, and 60% glycerol), 160 mM KCl,
and Heparin (final concentration 2.5 mg/ml), on a rotator at room
temperature for 30 minutes. The beads were then washed six times
with 1 ml of 1x solution D before the addition of SDS sample
buffer and loading on 12% SDS-polyacrylamide gels. Gels were
stained with Coomassie brilliant blue R250. The protein bands,
which were differentially enriched in the ISE wt and the ISE
mutated fractions, were excised from the gel and subjected to the
protein sequence analyses by applying the electrospray ionization
mass spectrometer (LCQ DECA XP-ThermoFinnigam). Frag-
Binding Properties of an Alu-Derived ISE
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identified by analysis of the peptide MS/MS data with Turbo
SEQUEST (Thermo Finnigam) and MASCOT (Matrix Science).
The primary antibodies that were applied in western blotting
analysis are: rabbit polyclonal anti-hnRNPA1 antibody (Santa
Cruz), rabbit polyclonal anti-DAZAP1 antibody (kindly provided
by E. Goina, ICGEB, Italy; 1:1000), goat polyclonal anti-HuR
(Santa Cruz, 1:800) and rabbit polyclonal anti-DHX36 (Bethyl
Laboratories, 1:1000).
Small interfering (siRNA) transfection
siRNA transfections were performed in HeLa cells using
Oligofectamine Reagent (Invitrogen). The sense strands of RNAi
oligos (Dharmacon and Sigma), which were used to silence the
target genes, are listed in the Table S2. 2.5610
5 HeLa cells were
plated in 60 mm plates and two rounds of transient transfection
with siRNA oligonucleotides against the proteins of interest were
performed. 24 hours after the second treatment with siRNA the
cells were transfected with the pATMD and pDSH5 minigene
constructs using Qiagen Effectene transfection reagents. After an
additional 24 hours the cells were collected and divided in two
equal fractions. The first one was used to extract the total RNA
and evaluate the effect of protein depletion on the splicing pattern
whereas the second fraction served to perform protein analysis in
order to evaluate the silencing effect of siRNAs.
Supporting Information
Figure S1 Over-expression of HuR, DAZAP1, hnRNPA1
and RNA helicase DHX36 proteins in HeLa cells. Western
blot analysis on HeLa cells non-transfected (2) and transfected (+)
with expression vectors for HuR, DAZAP1, hnRNPA1 and RNA
helicase DHX36. The proteins were tagged with flag and their
expression was detected using corresponding antibody.
(TIF)
Table S1 Oligonucleotide sequence for mutagenesis experi-
ments.
(DOC)
Table S2 Sequence of RNAi oligonucleotides.
(DOC)
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